[Histone deacetylase-targeted anti-leukemia therapy].
Ozawa
Yukiyasu
Y
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002454:Cell Differentiation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D056284:Histone Deacetylase 1; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000494:pharmacology*; D006801:Humans; D007938:Leukemia / Q000201:enzymology / Q000473:pathology*; D014157:Transcription Factors / Q000502:physiology; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D014157:Transcription Factors; D014212:Tretinoin; C110550:HDAC1 protein, human; D056284:Histone Deacetylase 1; D006655:Histone Deacetylases